Fields Psychiatry, Neuroscience | ||
 | ||
Institutions Institute of Psychiatry, Psychology and Neuroscience, King's College London Education All India Institute of Medical Sciences (MBBS)
Neuroscience at Institute of Medical Science, University of Toronto (PhD) Known for Schizophrenia and treatment
Alzheimer’s and treatment
Imaging and therapeutics Notable awards Joel Elkes Award of the American College of Neuropsychopharmacology (ACNP)
Paul Janssen Award of the International College of Neuropsychopharmacology (CINP)
A.E. Bennet Award of the Society for Biological Psychiatry
Research Prize from the World Congress of Biological Psychiatry Books Catecholamine Research in the 21st Century: The Enduring Centrality of Dopamine in the Pathophysiology of Schizophrenia: In Vivo Evidence from the Prodrome to the First Psychotic Episode Institution Institute of Psychiatry, Psychology and Neuroscience Similar Robin Murray, Peter McGuffin, Anthony David | ||
The story of psychosis lessons from men mice and molecules a talk by dr shitij kapur
Shitij Kapur, PhD, FMedSci, is the Dean of the Faculty of Medicine Dentistry and Health Sciences and Assistant Vice-Chancellor (Health) of the University of Melbourne. He was formerly of Dean and Head of School at the Institute of Psychiatry, Psychology and Neuroscience (IoPPN) at King's College London, and professor of psychiatry at the University of Toronto. Kapur’s research has made major contributions to the understanding of psychosis and antipsychotic treatment. He is a current executive committee member of the European College of Neuropsychopharmacology and leads NEWMEDS, an innovative medicines initiative.
Contents
Shitij kapur dopamine hypothesis lecture teaser
Research focus/interests
Professor Kapur’s research aims to understand the basis of psychosis and the improvement of antipsychotics through the use of brain imaging, clinical studies, and animal models.
Notable contributions to research
Kapur’s work on antipsychotics has made a huge impact on dosage. Through brain imaging and clinical studies, he has found that antipsychotics block dopamine D2 receptors to varying degrees, thereby making a strong argument for lower doses. His research has also contested the “delayed onset” theory of antipsychotics, suggesting that action begins within the first few days of treatment.
Past appointments
Prior to his current position as Dean and Professor of Psychiatry at King's College London, Kapur was a Professor of Psychiatry at the University of Toronto. While there, he served as Deputy and Section Head for Schizophrenia Research at the Centre for Addiction and Mental Health. From 2001 to 2007, he was the Canada Research Chair at the University of Toronto.
Awards
Kapur has won many awards, including the Joel Elkes Award of the American College of Neuropsychopharmacology (ACNP) in 2007, Paul Janssen Award of the International College of Neuropsychopharmacology (CINP), A.E. Bennett Award of the Society for Biological Psychiatry, and the Research Prize from the World Congress of Biological Psychiatry.
Positions of trust and research assessments
Kapur is an Executive Committee member of the European College of Neuropsychopharmacology. He served as secretary of the International College of Neuropsychopharmacology from 2009 to 2012. He is a founding board member of the Schizophrenia International Research Society and served on the Board of Trustees from 2010-14.
Kapur serves on numerous editorial boards, including those of Schizophrenia Research, Schizophrenia Bulletin, BMC Psychiatry, Archives of General Psychiatry, World Journal of Biological Psychiatry, American Journal of Psychiatry, and Neuropsychopharmacology.
He is an external grant referee for many research councils including the Medical Research Council, UK, the Medical Research Council of Canada, the Canadian Institutes of Health Research, the Stanley Research Foundation, USA, and the National Institute of Mental Health, NIH, USA.
Publications
Kapur has published extensively, with over 200 peer-reviewed articles.